drugset
drugset / Trial / NCT04938752

Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects (DA-2811)

NCT04938752 ↗

Phase 1 Completed 30 enrolled Dong-A ST Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

This is the phase I study to evaluate the pharmacokinetics and safety of DA-2811 and DA-2811-R after a single oral dose in healthy volunteers.

Timeline

Start
2021-07-08
Primary completion
2021-08-20
Completion
2021-08-20

Drugs

EvaluationDrugModalityDoseRoute
Subject DA-2811 Unknown — Oral
Subject DA-2811-R Unknown — Oral

Indications

No indication recorded.